Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

All Older AML Patients and Younger Patients with Adverse Biology Should Receive HMA/Venetoclax Instead of 3+7/Standard Induction

1,014 views
October 17, 2019
0 Comments
Login to view comments. Click here to Login